|
|
DSpace at RU >
Search Results
Results 1-50 of 92.
Item hits:
| Full Text | Issue Date | Title | Author(s) |  | 2011 | Spindle-assembly checkpoint and gastrointestinal cancer | Voer, R.M. de; Hoogerbrugge, N.; Kuiper, R.P. |
| | 2011 | [Familial gastric cancer: diagnosis, treatment and periodic surveillance] | Kluijt, I.; Sijmons, R.H.; Hoogerbrugge, N.; Vasen, H.F.; Cats, A. |
| | 2011 | [Familial history of ovarian carcinoma: policy] | Hullu, J.A. de; Kets, C.M.; Massuger, L.F.A.G.; Ligtenberg, M.L.; Ham, M.A. van; Hoogerbrugge, N. |
| | 2011 | A non-BRCA1/2 hereditary breast cancer sub-group defined by aCGH profiling of genetically related patients | Didraga, M.A.; Beers, E.H. van; Joosse, S.A.; Brandwijk, K.I.; Oldenburg, R.A.; Wessels, L.F.; Hogervorst, F.B.L.; Ligtenberg, M.J.L.; Hoogerbrugge, N.; Verhoef, S.; Devilee, P.; Nederlof, P.M. |
| | 2011 | Lynch syndrome-associated extracolonic tumors are rare in two extended families with the same EPCAM deletion | Lynch, H.T.; Riegert-Johnson, D.L.; Snyder, C.; Lynch, J.F.; Hagenkord, J.; Boland, C.R.; Rhees, J.; Thibodeau, S.N.; Boardman, L.A.; Davies, J.; Kuiper, R.P.; Hoogerbrugge, N.; Ligtenberg, M.J.L. |
 | 2011 | Group medical visits in the follow-up of women with a BRCA mutation: design of a randomized controlled trial | Visser, A.; Prins, J.B.; Hoogerbrugge, N.; Laarhoven, H.W.M. van |
 | 2011 | Shortened time interval between colorectal cancer diagnosis and risk testing for hereditary colorectal cancer is not related to higher psychological distress | Landsbergen, K.M.; Prins, J.B.; Brunner, H.G.; Hoogerbrugge, N. |
| | 2011 | Constitutive expression of gamma-H2AX has prognostic relevance in triple negative breast cancer | Nagelkerke, A.P.; Kuijk, S.J. van; Sweep, F.C.; Nagtegaal, I.D.; Hoogerbrugge, N.; Martens, J.W.; Timmermans, M.A.Y.; Laarhoven, H.W.M. van; Bussink, J.; Span, P.N. |
| | 2011 | Identification of candidate predisposing copy number variants in familial and early-onset colorectal cancer patients | Venkatachalam, R.; Verwiel, E.T.P.; Kamping, E.J.; Hoenselaar, E.; Gorgens, H.; Schackert, H.K.; Krieken, J.H. van; Ligtenberg, M.J.L.; Hoogerbrugge, N.; Geurts van Kessel, A.H.M.; Kuiper, R.P. |
| | 2011 | Adding familial risk assessment to faecal occult blood test can increase the effectiveness of population-based colorectal cancer screening | Dekker, N.; Rossum, L.G.M. van; Vugt-van Pinxteren, M.W. van; Stiphout, S.H. van; Hermens, R.P.M.G.; Zelst-Stams, W.A.G. van; Oijen, M.G.H. van; Laheij, R.J.F.; Jansen, J.B.M.J.; Hoogerbrugge, N. |
| | 2011 | Common genetic variation at BARD1 is not associated with breast cancer risk in BRCA1 or BRCA2 mutation carriers | Spurdle, A.B.; Marquart, L.; McGuffog, L.; Healey, S.; Sinilnikova, O.; Wan, F.; Chen, X.; Beesley, J.; Singer, C.F.; Dressler, A.C.; Gschwantler-Kaulich, D.; Blum, J.L.; Tung, N.; Weitzel, J.; Lynch, H.; Garber, J.; Easton, D.F.; Peock, S.; Cook, M.; Oliver, C.T.; Frost, D.; Conroy, D.; Evans, D.G.; Lalloo, F.; Eeles, R.; Izatt, L.; Davidson, R.; Chu, C.; Eccles, D.; Selkirk, C.G.; Daly, M.; Isaacs, C.; Stoppa-Lyonnet, D.; Sinilnikova, O.M.; Buecher, B.; Belotti, M.; Mazoyer, S.; Barjhoux, L.; Verny-Pierre, C.; Lasset, C.; Dreyfus, H.; Pujol, P.; Collonge-Rame, M.A.; Rookus, M.A.; Verhoef, S.; Kriege, M.; Hoogerbrugge, N.; Ausems, M.G.; Os, T.A. van; Wijnen, J.; Devilee, P.; Meijers-Heijboer, H.E.; Blok, M.J.; Heikkinen, T.; Nevanlinna, H.; Jakubowska, A.; Lubinski, J.; Huzarski, T.; Byrski, T.; Durocher, F.; Couch, F.J.; Lindor, N.M.; Wang, X.; Thomassen, M.; Domchek, S.; Nathanson, K.; Caligo, M.; Jernstrom, H.; Liljegren, A.; Ehrencrona, H.; Karlsson, P.; Ganz, P.A.; Olopade, O.I.; Tomlinson, G.; Neuhausen, S.; Antoniou, A.C.; Chenevix-Trench, G.; Rebbeck, T.R. |
| | 2011 | Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation | Jongmans, M.C.J.; Burgt, I. van der; Hoogerbrugge, P.M.; Noordam, K.; Yntema, H.G.; Nillesen, W.M.; Kuiper, R.P.; Ligtenberg, M.J.L.; Geurts van Kessel, A.H.M.; Krieken, J.H. van; Kiemeney, L.A.L.M.; Hoogerbrugge, N. |
| | 2011 | Young age and a positive family history of colorectal cancer are complementary selection criteria for the identification of Lynch syndrome | Manders, P.; Spruijt, L.; Kets, C.M.; Willems, H.W.; Bodmer, D.; Hebeda, K.M.; Nagtegaal, I.D.; Krieken, J.H. van; Ligtenberg, M.J.L.; Hoogerbrugge, N. |
| | 2011 | Recurrence and variability of germline EPCAM deletions in Lynch syndrome | Kuiper, R.P.; Vissers, L.E.L.M.; Venkatachalam, R.; Bodmer, D.; Hoenselaar, E.; Goossens, M.; Haufe, A.; Kamping, E.J.; Niessen, R.C.; Hogervorst, F.B.L.; Gille, J.J.P.; Redeker, B.; Tops, C.M.; Gijn, M.E. van; Ouweland, A.M. van den; Rahner, N.; Steinke, V.; Kahl, P.; Holinski-Feder, E.; Morak, M.; Kloor, M.; Stemmler, S.; Betz, B.; Hutter, P.; Bunyan, D.J.; Syngal, S.; Culver, J.O.; Graham, T.; Chan, T.L.; Nagtegaal, I.D.; Krieken, J.H. van; Schackert, H.K.; Hoogerbrugge, N.; Geurts van Kessel, A.H.M.; Ligtenberg, M.J.L. |
| | 2011 | Body weight and risk of breast cancer in BRCA1/2 mutation carriers | Manders, P.; Pijpe, A.; Hooning, M.J.; Kluijt, I.; Vasen, H.F.; Hoogerbrugge, N.; Asperen, C.J. van; Meijers-Heijboer, H.; Ausems, M.G.; Os, T.A. van; Gomez-Garcia, E.B.; Brohet, R.M.; Leeuwen, F.E. van; Rookus, M.A.; Ligtenberg, M.J.L. |
| | 2011 | Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. | Cox, D.G.; Simard, J.; Sinnett, D.; Hamdi, Y.; Soucy, P.; Ouimet, M.; Barjhoux, L.; Verny-Pierre, C.; McGuffog, L.; Healey, S.; Szabo, C.; Greene, M.H.; Mai, P.L.; Andrulis, I.L.; Thomassen, M.; Gerdes, A.M.; Caligo, M.A.; Friedman, E.; Laitman, Y.; Kaufman, B.; Paluch, S.S.; Borg, A.; Karlsson, P.; Askmalm, M.S.; Bustinza, G.B.; Nathanson, K.L.; Domchek, S.M.; Rebbeck, T.R.; Benitez, J.; Hamann, U.; Rookus, M.A.; Ouweland, A.M. van den; Ausems, M.G.; Aalfs, C.M.; Asperen, C.J. van; Devilee, P.; Gille, H.J.; Peock, S.; Frost, D.; Evans, D.G.; Eeles, R.; Izatt, L.; Adlard, J.; Paterson, J.; Eason, J.; Godwin, A.K.; Remon, M.A.; Moncoutier, V.; Gauthier-Villars, M.; Lasset, C.; Giraud, S.; Hardouin, A.; Berthet, P.; Sobol, H.; Eisinger, F.; Bressac de Paillerets, B.; Caron, O.; Delnatte, C.; Goldgar, D.; Miron, A.; Ozcelik, H.; Buys, S.; Southey, M.C.; Terry, M.B.; Singer, C.F.; Dressler, A.C.; Tea, M.K.; Hansen, T.V.; Johannsson, O.; Piedmonte, M.; Rodriguez, G.C.; Basil, J.B.; Blank, S.; Toland, A.E.; Montagna, M.; Isaacs, C.; Blanco, I.; Gayther, S.A.; Moysich, K.B.; Schmutzler, R.K.; Wappenschmidt, B.; Engel, C.; Meindl, A.; Ditsch, N.; Arnold, N.; Niederacher, D.; Sutter, C.; Gadzicki, D.; Fiebig, B.; Caldes, T.; Laframboise, R.; Nevanlinna, H.; Chen, X.; Beesley, J.; Spurdle, A.B.; Neuhausen, S.L.; Ding, Y.C.; Couch, F.J.; Wang, X.; Peterlongo, P.; Manoukian, S.; Bernard, L.; Radice, P.; Easton, D.F.; Chenevix-Trench, G.; Antoniou, A.C.; Stoppa-Lyonnet, D.; Mazoyer, S.; Sinilnikova, O.M.; Ligtenberg, M.J.L.; Hoogerbrugge, N. |
| | 2011 | Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers | Im, K.M.; Kirchhoff, T.; Wang, X.; Green, T.; Chow, C.Y.; Vijai, J.; Korn, J.; Gaudet, M.M.; Fredericksen, Z.; Shane Pankratz, V.; Guiducci, C.; Crenshaw, A.; McGuffog, L.; Kartsonaki, C.; Morrison, J.; Healey, S.; Sinilnikova, O.M.; Mai, P.L.; Greene, M.H.; Piedmonte, M.; Rubinstein, W.S.; Hogervorst, F.B.L.; Rookus, M.A.; Collee, J.M.; Hoogerbrugge, N.; Asperen, C.J. van; Meijers-Heijboer, H.E.; Roozendaal, C.E.P. van; Caldes, T.; Perez-Segura, P.; Jakubowska, A.; Lubinski, J.; Huzarski, T.; Blecharz, P.; Nevanlinna, H.; Aittomaki, K.; Lazaro, C.; Blanco, I.; Barkardottir, R.B.; Montagna, M.; D'Andrea, E.; Devilee, P.; Olopade, O.I.; Neuhausen, S.L.; Peissel, B.; Bonanni, B.; Peterlongo, P.; Singer, C.F.; Rennert, G.; Lejbkowicz, F.; Andrulis, I.L.; Glendon, G.; Ozcelik, H.; Toland, A.E.; Caligo, M.A.; Beattie, M.S.; Chan, S.; Domchek, S.M.; Nathanson, K.L.; Rebbeck, T.R.; Phelan, C.; Narod, S.; John, E.M.; Hopper, J.L.; Buys, S.S.; Daly, M.B.; Southey, M.C.; Terry, M.B.; Tung, N.; Hansen, T.V.; Osorio, A.; Benitez, J.; Duran, M.; Weitzel, J.N.; Garber, J.; Hamann, U.; Peock, S.; Cook, M.; Oliver, C.T.; Frost, D.; Platte, R.; Evans, D.G.; Eeles, R.; Izatt, L.; Paterson, J.; Brewer, C.; Hodgson, S.; Morrison, P.J.; Porteous, M.; Walker, L.; Rogers, M.T.; Side, L.E.; Godwin, A.K.; Schmutzler, R.K.; Wappenschmidt, B.; Laitman, Y.; Meindl, A.; Deissler, H.; Varon-Mateeva, R.; Preisler-Adams, S.; Ligtenberg, M.J.L. |
| | 2011 | Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study | Kempers, M.J.E.; Kuiper, R.P.; Ockeloen, C.W.; Chappuis, P.O.; Hutter, P.; Rahner, N.; Schackert, H.K.; Steinke, V.; Holinski-Feder, E.; Morak, M.; Kloor, M.; Buttner, R.; Verwiel, E.T.P.; Krieken, J.H. van; Nagtegaal, I.D.; Goossens, M.; Post, R.S. van der; Niessen, R.C.; Sijmons, R.H.; Kluijt, I.; Hogervorst, F.B.L.; Leter, E.M.; Gille, J.J.P.; Aalfs, C.M.; Redeker, E.J.; Hes, F.J.; Tops, C.M.; Nesselrooij, B.P. van; Gijn, M.E. van; Gomez Garcia, E.B.; Eccles, D.M.; Bunyan, D.J.; Syngal, S.; Stoffel, E.M.; Culver, J.O.; Palomares, M.R.; Graham, T.; Velsher, L.; Papp, J.; Olah, E.; Chan, T.L.; Leung, S.Y.; Geurts van Kessel, A.H.M.; Kiemeney, L.A.L.M.; Hoogerbrugge, N.; Ligtenberg, M.J.L. |
| | 2010 | Dokter, krijg ik nu ook kanker? : herkennen, behandelen en voorkomen van erfelijke kanker | Hoogerbrugge-van der Linden, N. |
| | 2010 | Association of the variants CASP8 D302H and CASP10 V410I with breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers. | Engel, C.; Versmold, B.; Wappenschmidt, B.; Simard, J.; Easton, D.F.; Peock, S.; Cook, M.; Oliver, C.; Frost, D.; Mayes, R.; Evans, D.G.; Eeles, R.; Paterson, J.; Brewer, C.; Tollenaar, R.A.E.M.; Hoogerbrugge, N.; Ligtenberg, M.J.L.; Ausems, M.G.E.M. |
| | 2010 | Germline epigenetic silencing of the tumor suppressor gene PTPRJ in early-onset familial colorectal cancer. | Venkatachalam, R.; Ligtenberg, M.J.L.; Hoogerbrugge, N.; Schackert, H.K.; Gorgens, H.; Hahn, M.M.; Kamping, E.J.; Basten-Vreede, L.A.J.; Hoenselaar, E.; Looij, E. van de; Goossens, M.; Churchman, M.; Carvajal-Carmona, L.; Tomlinson, I.P.; Bruijn, D.R.H. de; Geurts van Kessel, A.H.M.; Kuiper, R.P. |
| | 2010 | Novel RUNX1 mutations in familial platelet disorder with enhanced risk for acute myeloid leukemia: clues for improved identification of the FPD/AML syndrome. | Jongmans, M.C.J.; Kuiper, R.P.; Carmichael, C.L.; Wilkins, E.J.; Dors, N.; Carmagnac, A.; Schouten-van Meeteren, A.Y.; Li, X.; Stankovic, M.; Kamping, E.J.; Bengtsson, H.; Schoenmakers, E.F.P.M.; Geurts van Kessel, A.H.M.; Hoogerbrugge, P.M.; Hahn, C.N.; Brons, P.P.T.; Scott, H.S.; Hoogerbrugge-van der Linden, N. |
| | 2010 | BRCA1-associated breast cancers present differently from BRCA2-associated and familial cases: long-term follow-up of the Dutch MRISC Screening Study. | Rijnsburger, A.J.; Obdeijn, I.M.; Kaas, R.; Tilanus-Linthorst, M.M.; Boetes, C.; Loo, C.E.; Wasser, M.N.; Bergers, E.; Kok, T.; Muller, S.H.; Peterse, H.; Tollenaar, R.A.E.M.; Hoogerbrugge, N.; Meijer, S.; Bartels, C.C.; Seynaeve, C.; Hooning, M.J.; Kriege, M.; Schmitz, P.I.M.; Oosterwijk, J.C.; Koning, H.J. de; Rutgers, E.J.; Klijn, J.G.M. |
| | 2010 | Common genetic variants and modification of penetrance of BRCA2-associated breast cancer. | Gaudet, M.M.; Kirchhoff, T.; Green, T.; Vijai, J.; Korn, J.M.; Guiducci, C.; Segre, A.; McGee, K.; McGuffog, L.; Kartsonaki, C.; Morrison, J.; Healey, S.; Sinilnikova, O.M.; Stoppa-Lyonnet, D.; Mazoyer, S.; Gauthier-Villars, M.; Sobol, H.; Longy, M.; Frenay, I.H.; Hogervorst, F.B.L.; Rookus, M.A.; Collee, J.M.; Hoogerbrugge, N.; Roozendaal, C.E.P. van; Ligtenberg, M.J.L. |
| | 2010 | Noonan syndrome, the SOS1 gene and embryonal rhabdomyosarcoma. | Jongmans, M.C.J.; Hoogerbrugge, P.M.; Hilkens, L.; Flucke, U.E.; Burgt, C.J.A.M. van der; Noordam, C.; Ruiterkamp-Versteeg, M.; Yntema, H.G.; Nillesen, W.M.; Ligtenberg, M.J.L.; Geurts van Kessel, A.H.M.; Kuiper, R.P.; Hoogerbrugge, N. |
| | 2010 | The epigenetics of (hereditary) colorectal cancer. | Venkatachalam, R.; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N.; Bruijn, D.R.H. de; Kuiper, R.P.; Geurts van Kessel, A.H.M. |
| | 2010 | Germline copy number variation and cancer risk. | Kuiper, R.P.; Ligtenberg, M.J.L.; Hoogerbrugge, N.; Geurts van Kessel, A.H.M. |
| | 2010 | Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. | Antoniou, A.C.; Beesley, J.; McGuffog, L.; Sinilnikova, O.M.; Healey, S.; Neuhausen, S.L.; Ding, Y.C.; Rebbeck, T.R.; Weitzel, J.; Lynch, H.T.; Isaacs, C.; Ganz, P.A.; Tomlinson, G.; Olopade, O.I.; Couch, F.J.; Wang, X.; Lindor, N.; Pankratz, V.S.; Radice, P.; Manoukian, S.; Peissel, B.; Zaffaroni, D.; Barile, M.; Viel, A.; Allavena, A.; Dall'Olio, V.; Peterlongo, P.; Szabo, C.I.; Zikan, M.; Claes, K.; Poppe, B.; Foretova, L.; Mai, P.L.; Greene, M.H.; Rennert, G.; Lejbkowicz, F.; Glendon, G.; Ozcelik, H.; Andrulis, I.L.; Hoogerbrugge, N.; Luijt, R.B. van der; Asperen, C.J. van; Devilee, P.; Meijers-Heijboer, E.J.; Blok, M.J.; Aalfs, C.M.; Hogervorst, F.; Rookus, M.A.; Pauw, A. de; Ligtenberg, M.J.L.; Ausems, M.G.E.M. |
| | 2010 | Psychosocial impact of Von Hippel-Lindau disease: levels and sources of distress. | Lammens, C.R.; Bleiker, E.M.; Verhoef, S.; Hes, F.J.; Ausems, M.G.; Majoor-Krakauer, D.; Sijmons, R.H.; Luijt, R.B. van der; Ouweland, A.M. van den; Os, T.A. van; Hoogerbrugge, N.; Gomez Garcia, E.B.; Dommering, C.J.; Gundy, C.M.; Aaronson, N.K. |
| | 2010 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population. | Antoniou, A.C.; Wang, X.; Fredericksen, Z.; McGuffog, L.; Tarrell, R.; Sinilnikova, O.M.; Healey, S.; Morrison, J.; Kartsonaki, C.; Lesnick, T.; Ghoussaini, M.; Barrowdale, D.; Peock, S.; Cook, M.; Oliver, C.; Frost, D.; Eccles, D.; Evans, D.G.; Eeles, R.; Izatt, L.; Chu, C.; Douglas, F.; Paterson, J.; Stoppa-Lyonnet, D.; Houdayer, C.; Mazoyer, S.; Giraud, S.; Lasset, C.; Remenieras, A.; Caron, O.; Hardouin, A.; Berthet, P.; Hogervorst, F.B.L.; Rookus, M.A.; Jager, A.; Ouweland, A.M.W. van den; Hoogerbrugge, N.; Luijt, R.B. van der; Meijers-Heijboer, H.; Gomez Garcia, E.B.; Devilee, P.; Vreeswijk, M.P.; Lubinski, J.; Jakubowska, A.; Gronwald, J.; Huzarski, T.; Byrski, T.; Gorski, B.; Cybulski, C.; Spurdle, A.B.; Holland, H.; Goldgar, D.E.; John, E.M.; Hopper, J.L.; Southey, M.C.; Buys, S.S.; Daly, M.B.; Terry, M.B.; Schmutzler, R.K.; Wappenschmidt, B.; Engel, C.; Meindl, A.; Preisler-Adams, S.; Arnold, N.; Niederacher, D.; Sutter, C.; Domchek, S.M.; Nathanson, K.L.; Rebbeck, T.R.; Blum, J.L.; Piedmonte, M.; Rodriguez, G.C.; Wakeley, K.; Boggess, J.F.; Basil, J.; Blank, S.V.; Friedman, E.; Kaufman, B.; Laitman, Y.; Milgrom, R.; Andrulis, I.L.; Glendon, G.; Ozcelik, H.; Kirchhoff, T.; Vijai, J.; Gaudet, M.M.; Altshuler, D.; Guiducci, C.; Loman, N.; Harbst, K.; Rantala, J.; Ehrencrona, H.; Gerdes, A.M.; Thomassen, M.; Sunde, L.; Peterlongo, P.; Manoukian, S.; Bonanni, B.; Viel, A. |
| | 2010 | Female BRCA mutation carriers with a preference for prophylactic mastectomy are more likely to participate an educational-support group and to proceed with the preferred intervention within 2 years. | Landsbergen, K.M.; Prins, J.B.; Kamm, Y.J.L.; Brunner, H.G.; Hoogerbrugge-van der Linden, N. |
| | 2010 | Electronic reminders for pathologists promote recognition of patients at risk for Lynch syndrome: cluster-randomised controlled trial. | Overbeek, L.I.H.; Hermens, R.P.M.G.; Krieken, J.H.J.M. van; Adang, E.M.M.; Casparie, M.; Nagengast, F.M.; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N. |
| | 2010 | TP53 germline mutation testing in 180 families suspected of Li-Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes. | Ruijs, M.W.; Verhoef, S.; Rookus, M.A.; Pruntel, R.; Hout, A.H. van der; Hogervorst, F.B.L.; Kluijt, I.; Sijmons, R.H.; Aalfs, C.M.; Wagner, A.; Ausems, M.G.E.M.; Hoogerbrugge-van der Linden, N.; Asperen, C.J. van; Gomez Garcia, E.B.; Meijers-Heijboer, H.; Kate, L.P. Ten; Menko, F.H.; Veer, L.J. van 't |
| | 2010 | Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. | Fitzgerald, R.C.; Hardwick, R.; Huntsman, D.; Carneiro, F.; Guilford, P.; Blair, V.; Chung, D.C.; Norton, J.; Ragunath, K.; Krieken, J.H.J.M. van; Dwerryhouse, S.; Caldas, C.; Hoogerbrugge, N. |
| | 2010 | Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers. | Pijpe, A.; Manders, P.; Brohet, R.M.; Collee, J.M.; Verhoef, S.; Vasen, H.F.; Hoogerbrugge-van der Linden, N.; Asperen, C.J. van; Dommering, C.; Ausems, M.G.E.M.; Aalfs, C.M.; Gomez-Garcia, E.B.; Veer, L.J. van 't; Leeuwen, F.E. van; Rookus, M.A. |
| | 2010 | Improving calculation, interpretation and communication of familial colorectal cancer risk: protocol for a randomized controlled trial. | Dekker, N.; Hermens, R.P.M.G.; Elwyn, G.; Weijden, G.D.E.M. van der; Nagengast, F.M.; Duijvendijk, P. van; Salemink, S.; Adang, E.M.M.; Krieken, J.H.J.M. van; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N. |
| | 2010 | Risk of urothelial bladder cancer in Lynch syndrome is increased, in particular among MSH2 mutation carriers. | Post, R.S. van der; Kiemeney, L.A.L.M.; Ligtenberg, M.J.L.; Witjes, J.A.; Hulsbergen- van de Kaa, C.A.; Bodmer, D.; Schaap, L.; Kets, C.M.; Krieken, J.H.J.M. van; Hoogerbrugge-van der Linden, N. |
| | 2009 | Genetic testing offered directly after the diagnosis of colorectal cancer: a pilot study on the reactions af patients | Landsbergen, K.M.; Prins, J.B.; Brunner, H.G.; Hoogerbrugge, N. |
| | 2009 | Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon variant c.1A>G of MSH2. | Kets, M.; Hoogerbrugge-van der Linden, N.; Krieken, J.H.J.M. van; Goossens, M.; Brunner, H.G.; Ligtenberg, M.J.L. |
| | 2009 | Immunohistochemistry is not an accurate first step towards the molecular diagnosis of MUTYH-associated polyposis. | Post, R.S. van der; Kets, M.; Ligtenberg, M.J.L.; Krieken, J.H.J.M. van; Hoogerbrugge-van der Linden, N. |
| | 2009 | Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3' exons of TACSTD1. | Ligtenberg, M.J.L.; Kuiper, R.P.; Chan, T.L.; Goossens, M.; Hebeda, K.M.; Voorendt, M.; Lee, T.Y.; Bodmer, D.; Hoenselaar, E.; Hendriks-Cornelissen, S.J.; Tsui, W.Y.; Kong, C.K.; Brunner, H.G.; Geurts van Kessel, A.H.M.; Yuen, S.T.; Krieken, J.H.J.M. van; Leung, S.Y.; Hoogerbrugge-van der Linden, N. |
| | 2009 | In Lynch syndrome adenomas, loss of mismatch repair proteins is related to an enhanced lymphocytic response. | Meijer, T.W.; Hoogerbrugge-van der Linden, N.; Nagengast, F.M.; Ligtenberg, M.J.L.; Krieken, J.H.J.M. van |
| | 2009 | The tumor suppressor gene FBXW7 is disrupted by a constitutional t(3;4)(q21;q31) in a patient with renal cell cancer. | Kuiper, R.P.; Basten-Vreede, L.A.J.; Venkatachalam, R.; Ricketts, C.; Kamping, E.J.; Verwiel, E.T.P.; Govaerts, L.; Debiec-Rychter, M.; Lerut, E.; Erp, C.A. van; Hoogerbrugge-van der Linden, N.; Kempen, L.C.L.T. van; Schoenmakers, E.F.P.M.; Bonne, A.; Maher, E.R.; Geurts van Kessel, A.H.M. |
| | 2009 | A simple method for co-segregation analysis to evaluate the pathogenicity of unclassified variants; BRCA1 and BRCA2 as an example | Mohammadi, L.; Vreeswijk, M.P.; Oldenburg, R.; Ouweland, A.M.W. van den; Oosterwijk-Wakka, J.C.; Hout, A.H. van der; Hoogerbrugge-van der Linden, N.; Ligtenberg, M.J.L.; Ausems, M.G.E.M.; Luijt, R.B. van der; Dommering, C.J.; Gille, J.J.P.; Verhoef, S.; Hogervorst, F.B.L.; Os, T.A. van; Gomez Garcia, E.B.; Blok, M.J.; Wijnen, J.T.; Helmer, Q.; Devilee, P.; Asperen, C.J. van; Houwelingen, H.C. van |
| | 2009 | A method to assess the clinical significance of unclassified variants in the BRCA1 and BRCA2 genes based on cancer family history. | Gomez Garcia, E.B.; Oosterwijk-Wakka, J.C.; Timmermans, M.; Asperen, C.J. van; Hogervorst, F.B.L.; Hoogerbrugge-van der Linden, N.; Oldenburg, R.; Verhoef, S.; Dommering, C.J.; Ausems, M.G.E.M.; Os, T.A. van; Hout, A.H. van der; Ligtenberg, M.J.L.; Ouweland, A.M.W. van den; Luijt, R.B. van der; Wijnen, J.T.; Gille, J.J.P.; Lindsey, P.; Devilee, P.; Blok, M.J.; Vreeswijk, M.P. |
| | 2009 | Genetic testing for Lynch syndrome in the first year of colorectal cancer: a review of the psychological impact. | Landsbergen, K.M.; Prins, J.B.; Brunner, H.G.; Kraaimaat, F.W.; Hoogerbrugge-van der Linden, N. |
| | 2009 | Incidence of cancer in first-degree relatives of basal cell carcinoma patients. | Rossum, M.M. van; Wopereis, D.; Hoyer, T.; Soerjomataram, I.; Schalkwijk, J.; Kerkhof, P.C.M. van de; Kiemeney, L.A.L.M.; Hoogerbrugge-van der Linden, N. |
| | 2009 | Improvement of endometrial biopsy over transvaginal ultrasound alone for endometrial surveillance in women with Lynch syndrome. | Gerritzen, L.H.; Hoogerbrugge-van der Linden, N.; Oei, A.L.M.; Nagengast, F.M.; Ham, M.A.P.C. van; Massuger, L.F.A.G.; Hullu, J.A. de |
| | 2009 | Prediction of BRCA1-association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. | Joosse, S.A.; Beers, E.H. van; Tielen, I.H.; Horlings, H.; Peterse, J.L.; Hoogerbrugge-van der Linden, N.; Ligtenberg, M.J.L.; Wessels, L.F.; Axwijk, P.; Verhoef, S.; Hogervorst, F.B.L.; Nederlof, P.M. |
| | 2009 | Deficient mismatch repair system in patients with sporadic advanced colorectal cancer. | Koopman, M.; Kortman, G.A.; Mekenkamp, L.; Ligtenberg, M.J.L.; Hoogerbrugge-van der Linden, N.; Antonini, N.F.; Punt, C.J.A.; Krieken, J.H.J.M. van |
1
2
next
|
